Daily pill can double survival time for deadliest cancer, trial shows
daraxonrasibpancreatic cancercancer researchsurvival timeclinical trial
Author: c-oreills
Date: 5/31/2026
Article Summary:
A clinical trial shows that a daily pill, daraxonrasib, can double survival time for patients with advanced pancreatic cancer, a type of cancer that is often found late and has few treatment options.